DSpace at RU >

Browsing by Author Teichert, M.

Full Text	Issue Date	Title	Author(s)
	2012	Concomitant use of contraceptives and potentially teratogenic medicinal products--results from a study using pharmacy dispensing data in the Netherlands	Ruiter, R. de; Teichert, M.; Straus, S.M.; Stricker, B.H.; Visser, L.E.
	2012	Evaluation of the effect of genetic variations in GATA-4 on the phenprocoumon and acenocoumarol maintenance dose	van Schie, R.M.; Wessels, J.A.M.; Verhoef, T.I.; Schalekamp, T.; le Cessie, S., et al
	2012	Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original study	van Schie, R.M.; el Khedr, N.; Verhoef, T.I.; Teichert, M.; Stricker, B.H., et al
	2011	Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes	Teichert, M.; Eijgelsheim, M.; Uitterlinden, A.G.; Buhre, P.N.; Hofman, A., et al
	2011	Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment.	Teichert, M.; Noord, C. van; Uitterlinden, A.G.; Hofman, A.; Buhre, P.N., et al
	2011	Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.	Teichert, M.; Visser, L.E.; Uitterlinden, A.G.; Hofman, A.; Buhre, P.J., et al
	2010	Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.	Teichert, M.; Visser, L.E.; Dufour, M.; Rodenburg, E.; Straus, S.M., et al
	2009	A genome-wide association study of acenocoumarol maintenance dosage.	Teichert, M.; Eijgelsheim, M.; Rivadeneira, F.; Uitterlinden, A.G.; Schaik, R.H. van, et al
	2009	Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period.	Teichert, M.; Schaik, R.H. van; Hofman, A.; Uitterlinden, A.G.; Smet, P.A.G.M. de, et al
	2008	Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study.	Teichert, M.; Visser, L.E.; Schaik, R.H. van; Hofman, A.; Uitterlinden, A.G., et al
	2008	Leidt een goed FTO tot beter voorschrijven?	Eimers, M.; Aalst, A. van der; Pelzer, B.J.; Teichert, M.; Wit, H. de
	2007	How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?	Teichert, M.; Aalst, A. van der; Wit, H. de; Stroo, M.; Smet, P.A.G.M. de
	2007	Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly.	Teichert, M.; Smet, P.A.G.M. de; Hofman, A.; Witteman, J.C.; Stricker, B.H.C.
	2006	Decline in prolonged hormone replacement therapy in women aged 45 years or more, and impact of a centralised database tool.	Teichert, M.; Baart, F.; Smet, P.A.G.M. de
	2005	Vraagtekens bij 'hormoonpaniek'. Hormonensearch WINAp/SFK nog steeds valide.	Teichert, M.; Smet, P.A.G.M. de
	2004	Hormoongebruik in de overgang. Zeker uw zorg waard.	Teichert, M.; Smet, P.A.G.M. de